Erythrasma epidemiology and demographics

Jump to navigation Jump to search

Erythrasma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erythrasma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erythrasma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Erythrasma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erythrasma epidemiology and demographics

on Erythrasma epidemiology and demographics

Erythrasma epidemiology and demographics in the news

Blogs on Erythrasma epidemiology and demographics

Directions to Hospitals Treating Erythrasma

Risk calculators and risk factors for Erythrasma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

Global epidemiological and demographical information for erythrasma is not well documented. Among diagnosis of dermatomycoses, the incidence of erythrasma was approximated as 4,500 per 100,000 individuals in 1951. Studies on erythrasma prevalence have found high rates in military populations. Erythrasma is most common in individuals over 40 years old. Women are more commonly affected by erythrasma than men. There is no known racial predisposition to erythrasma. Erythrasma of the groin is more commonly found in humid, tropical or subtropical regions; interdigital erythrasma does not have a geographic predisposition.

Epidemiology and Demographics

Incidence

  • Among diagnosis of dermatomycoses, the incidence of erythrasma was approximated as 4,500 per 100,000 individuals in 1951.[1]
    • Erythrasma of the groin was approximated as 3,000 per 100,000 individuals.

Prevalence

  • Studies on erythrasma prevalence have found high rates in military populations.
    • The prevalence of erythrasma is approximately 77.1% in Danish military recruits.[2]
    • The prevalence of erythrasma is approximately 41.7% in South Korean soldiers.[3]

Age

  • Erythrasma is most common in individuals over 40 years old.[4][5]

Gender

  • Women are more commonly affected by erythrasma than men.[4][5]

Race

There is no racial predisposition to erythrasma.

Developing and Developed Countries

  • Erythrasma of the groin is most commonly found in humid tropical and sub-tropical climates.[1]
    • Interdigital erythrasma does not have a geographic predisposition.

References

  1. 1.0 1.1 Sarkany, I. (1962). "Incidence and Bacteriology of Erythrasma". Archives of Dermatology. 85 (5): 578. doi:10.1001/archderm.1962.01590050008002. ISSN 0003-987X.
  2. Svejgaard E, Christophersen J, Jelsdorf HM (1986). "Tinea pedis and erythrasma in Danish recruits. Clinical signs, prevalence, incidence, and correlation to atopy". J. Am. Acad. Dermatol. 14 (6): 993–9. PMID 3722494.
  3. Rho, Nark-Kyoung; Kim, Beom-Joon (2008). "A corynebacterial triad: Prevalence of erythrasma and trichomycosis axillaris in soldiers with pitted keratolysis". Journal of the American Academy of Dermatology. 58 (2): S57–S58. doi:10.1016/j.jaad.2006.05.054. ISSN 0190-9622.
  4. 4.0 4.1 Polat, Muhterem; İlhan, Mustafa N. (2015). "The Prevalence of Interdigital Erythrasma". Journal of the American Podiatric Medical Association. 105 (2): 121–124. doi:10.7547/0003-0538-105.2.121. ISSN 8750-7315.
  5. 5.0 5.1 Morales-Trujillo ML, Arenas R, Arroyo S (2008). "[Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings]". Actas Dermosifiliogr (in Spanish; Castilian). 99 (6): 469–73. PMID 18558055.